Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
62.03
-0.58 (-0.93%)
At close: Oct 30, 2026, 4:00 PM EDT
61.99
-0.04 (-0.06%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $9.76 billion as of October 30, 2026. It is the 2,164th most valuable company in the world and the 777th biggest in the United States. Its market cap has increased by 72.80% in one year.
Market Cap
9.76B
Enterprise Value
8.39B
1-Year Change
72.80%
Global Rank
Country Rank
#777 United States
Category
ChartMarket Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $9.76B, an increase of 607.47%. That is a compound annual growth rate of 35.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 9.76B | 61.64% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 11.13B |
| Twist Bioscience | 10.88B |
| Caris Life Sciences | 10.21B |
| Kymera Therapeutics | 10.19B |
| Madrigal Pharmaceuticals | 9.97B |
| Krystal Biotech | 9.61B |
| Protagonist Therapeutics | 9.34B |
| Corcept Therapeutics | 9.29B |